Non–Small Cell Lung Cancer Coverage from Every Angle
ABOUT
SECTIONS
JNCCN Spotlights
Videos
News
Medical Literature
CE Activities
Clinical Trials
For Your Patients
NCCN RESOURCES
NCCN Guidelines
®
NCCN Compendium
®
NCCN Templates
®
NCCN Guidelines for Patients®
360 HUB
Advanced Skin Cancers
CLL/MCL
Multiple Myeloma
Non–Small Cell Lung Cancer
Ovarian Cancer
JNCCN
Editor:
Gregory J. Riely, MD, PhD
Advertisement
Advertisement
JNCCN Spotlights
Repotrectinib for
ROS1
-Positive NSCLC
(NEW Update) Nivolumab in NSCLC
(NEW Update) Pembrolizumab in NSCLC
Sotorasib
Dabrafenib + Trametinib (Tafinlar + Mekinist)
Pembrolizumab (Keytruda)
(UPDATE) Nivolumab (Opdivo) in NSCLC
Nivolumab (Opdivo)
JNCCN Spotlights
?
Sotorasib
(NEW Update) Nivolumab in NSCLC
Dabrafenib + Trametinib
View More >
Advertisement
Resources
For your Patients
Copyright ©
2026
National Comprehensive Cancer Network, All Rights Reserved
Bots not welcome here
